Time for the AAA approach? Anti-TNF, Anti-JAK, Artificial Intelligence

Chairperson: Prof. Tatsuya Atsumi

11:10

Welcome & Introduction

11:15

AI and Other New Technologies in Rheumatology
Prof. Laurent Arnaud

11:35

Discontinuation of Targeted Synthetic DMARDs After Achieving Clinical Remission in Rheumatoid Arthritis Treatment
Dr. Satoshi Kubo

11:50

Patient Profile Suitable for Enbrel Use in Our Center
Dr. Satoshi Ito

12:05

Q&A, Summary

Prof. Tatsuya Atsumi